Clinical Trials Logo

Mitral Valve Failure clinical trials

View clinical trials related to Mitral Valve Failure.

Filter by:
  • None
  • Page 1

NCT ID: NCT05023590 Enrolling by invitation - Atrial Fibrillation Clinical Trials

Atrial Fibrillation Registry 2017

Start date: February 22, 2017
Phase: N/A
Study type: Interventional

Monocentric, prospective, randomized trial of cardiac surgical arrhythmia using endocardial radiofrequency atrial ablation compared with a cryo ablation system in the setting of cardiac surgery.

NCT ID: NCT04717570 Active, not recruiting - Clinical trials for Mitral Valve Disease

Early Feasibility Study for the Foldax TRIA Mitral Heart Valve Replacement

FOLDAX
Start date: February 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to conduct the initial clinical investigation of the Foldax Polymer Mitral Valve to collect evidence on the device's safety and performance. The study is anticipated to confirm successful clinical safety and clinical effectiveness with significant improvements in clinical hemodynamic performance.

NCT ID: NCT03661398 Active, not recruiting - Clinical trials for Mitral Regurgitation

Caisson Transcatheter Mitral Valve Replacement (TMVR)

INTERLUDE
Start date: July 20, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the safety and performance of Transcatheter Mitral Valve Replacement (TMVR) system for the treatment of severe, symptomatic mitral regurgitation (MR).

NCT ID: NCT03015194 Completed - Clinical trials for Mitral Valve Failure

NHLBI DIR LAMPOON Study: Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Implantation

Start date: June 20, 2017
Phase: N/A
Study type: Interventional

Background: Transcatheter mitral valve replacement (TMVR) is recommended for some people with mitral valve heart problems. But the usual TMVR techniques might cause an obstruction for some people. A new technique is called LAMPOON. It may have less risk of obstruction. Participants in this study will be among the first in the world to have this technique done. Objectives: To test the safety and effectiveness of the LAMPOON technique in TMVR. Eligibility: Adults ages 21 and over who are recommended to have TMVR with LAMPOON Design: Participants will be screened with medical history and exam and by review of medical records. Participants will have blood tests, an ECG, a heart CT scan, and an echocardiogram before the procedure. Participants will have TMVR with LAMPOON. They will have anesthesia or moderate sedation for the procedure. Doctors will use a wire to split the diseased mitral valve and move it out of the way before inserting the artificial mitral valve. Participants will recover in an inpatient recovery unit. They will repeat the previous tests before leaving the hospital, 1 month later, 6 months later and 1 year later. They will have yearly follow-up phone calls for about 5 years. In the event of a participant's death, researchers will ask for an autopsy and to analyze the heart. Permission for this is not required as part of the study.